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Zika virus outbreak in the Americas: the need for novel 
mosquito control methods
Local transmission of Zika virus (ZIKV) in the Americas 
was ﬁ rst conﬁ rmed in February, 2014, on Easter Island. In 
May, 2015, 16 patients from the Brazilian states of Bahia 
and Rio Grande do Norte were found to be ZIKV-positive. 
22 countries and territories have subsequently 
identiﬁ ed autochthonous transmission within the 
region (ﬁ gure). Until recently, ZIKV infection was only 
associated with mild symptoms (headache, rash, joint 
pain, conjunctivitis) but a possible link between ZIKV 
infection during pregnancy and subsequent birth 
defects (most notably microcephaly) was identiﬁ ed in 
November, 2015.1 Approaching 4000 cases of suspected 
ZIKV-related microcephaly have arisen in Brazil alone 
where initial ﬁ gures suggest between 440 000 and 
1·3 million people have been infected so far.2 Concern in 
the region is escalating, with public health authorities in 
Colombia, Ecuador, El Salvador, and Jamaica all issuing 
an unprecedented health notice warning their residents 
to avoid pregnancy until 2018.
ZIKV is a ﬂ avivirus related to dengue virus (DENV) and 
historically has been transmitted by the same mosquito 
species, Aedes aegypti (ﬁ gure). There is no available 
treatment or vaccine so disease control is limited to the 
management of mosquitoes which currently relies on 
either insecticides or the destruction of larval breeding 
sites. In Brazil, ultra-low-volume space spraying is 
recommended only during dengue outbreaks. However, 
widespread insecticide resistance (including high 
pyreth roid resistance rates)3 and the impracticality of 
identifying and eliminating standing pools of water on 
a city-wide scale provide little hope for the containment 
of this disease. Vaccine development is anticipated to 
take several years; in the more immediate term, what 
options are left for the control of ZIKV?
Two novel approaches that have shown considerable 
promise in recent years are the genetic control 
of A aegypti mosquitoes and the development of 
mosquitoes that are resistant to arbovirus infection. 
The ﬁ rst ﬁ eld-trialled genetic control strategy is known 
as RIDL (the Release of Insects carrying Dominant Lethal 
genes) and involves the mass rearing of A aegypti that 
have been genetically modiﬁ ed to express a repressible 
lethal gene.4 During their rearing in insectaries, the 
mosquitoes are provided with a dietary supplement 
not present in nature (eg, tetracycline), and this 
supplement represses the lethal gene activation. Only 
male mosquitoes are released and these compete with 
wild males to mate with wild females. Oﬀ spring do not 
survive to the adult stage because they do not receive 
the dietary additive in the wild. Lines of RIDL males have 
been shown to have minimal ﬁ tness costs (ie, they are 
competitive with wild males) and the recent ﬁ eld release 
in Bahia, Brazil, reportedly achieved a 95% reduction in 
local mosquito populations.5
An alternative approach is the use of endosymbiotic 
bacteria to prevent arboviruses replicating within the 
mosquito. The Eliminate Dengue project has been 
able to demonstrate that Wolbachia bacteria from 
Drosophila fruit ﬂ ies can prevent DENV transmission in 
A aegypti mosquitoes without signiﬁ cant ﬁ tness costs.6 
Figure: Current distribution of Aedes aegypti and suspected distribution of ZIKV in the Americas (Brazil and 
USA are shown at state level)
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Wolbachia has also been shown to inhibit the replication 
of additional arboviruses such as chikungunya virus 
and yellow fever virus, strongly suggesting potential 
inhibitory eﬀ ects against ZIKV. 
Whereas RIDL is a self-limiting approach (the genetic 
modiﬁ cation is not perpetuated in wild populations), 
Wolbachia-based control strategies rely on this endo-
symbiont successfully invading wild mosquito pop-
ulations through a reproductive phenotype known as 
cytoplasmic incompatibility. This phenotype results in 
the generation of inviable oﬀ spring when an uninfected 
female mates with a Wolbachia-infected male. By contrast, 
Wolbachia-infected females can produce viable progeny 
when they mate with both infected and uninfected males, 
resulting in a reproductive advantage over uninfected 
females. Wolbachia-infected A aegypti mosquitoes were 
released and successfully invaded wild populations in 
Australia7 and releases are ongoing in DENV-endemic 
countries such as Indonesia, Vietnam, and Brazil. 
What eﬀ ect either RIDL or Wolbachia will have on 
arboviral transmission and epidemiology in the ﬁ eld 
remains uncertain. Mathematical models of DENV 
transmission incorporating the dynamics of viral infection 
in humans and mosquitoes predict that one strain of 
Wolbachia (wMel) would reduce the basic reproduction 
number, R0, of DENV transmission by 70%.8 Models of 
DENV transmission control with RIDL also project high 
eﬃ  cacy in reducing disease burden.9 These projections 
suggest that such strategies could have a direct impact on 
transmission of arboviruses such as ZIKV in countries such 
as Brazil where A aegypti is the principle vector. 
An important beneﬁ t of these environmentally 
friendly, species-speciﬁ c approaches is the reduced 
dependence they pose for insecticides—an increasingly 
important feature of future disease vector control. 
Moreover, suppressing the mosquito population, or 
rendering it arbovirus-resistant, holds great potential in 
the simultaneous control of ZIKV, DENV, chikungunya, 
and yellow fever viruses. 150 countries presently have 
A aegypti and are vulnerable to future outbreaks with all 
of these viruses. The costs of implementing these novel 
technologies in Brazil and across the tropics must be 
considered in the context of the multifaceted beneﬁ ts 
they pose in controlling several emerging infectious 
diseases.
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